skip to main content skip to accessibility policy

Articles & Updates – Details

8 July 2011

Surgical Methods in the Wake of G1/07 – Technical Board of Appeal Decision T0663/02

David Al-Khalili

In T0663/02 (17 March 2011) it was decided that the injection of a magnetic resonance contrast agent into a vein does not render the claim excluded from patentability on the basis that “the placement of an intravenous catheter is one of the most common invasive procedures performed in hospitals and consulting rooms” and was routinely delegated by a physician to a qualified paramedical professional.

As such, it was not considered as an intervention which represented the 'core of the medical profession’s activities' as required by G1/07 and thus was not excluded by A53(c) EPC.

T0663/02 also provides a 'risk matrix'. The matrix combines the levels of likelihood and health impact of a complication of a medical act with regard to a large number of patients, so as to obtain statistical health risk scores. The Board used the risk matrix to confirm that intravenous injections may be considered as minor routine interventions involving no substantial health risks.

A full report will be published shortly in our August 2011 patent newsletter.

Useful links

EPO decision T0663/02

 

Bookmark and Share
News

Send to a Friend

We are glad that you have found this page of interest. Please use this form to send your friend an email link to this page.





The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party.

Follow us

Newsletter subscriptions

In support of our environmental policy we encourage email subscriptions to receive our patent and trade mark newsletters as soon as they are published.








For RSS users

Our RSS news feeds allow you to see when we have added new content to our website so you can get the latest site updates in one place, as soon as they are published.

Social media

Privacy Policy

We are committed to protecting and respecting your privacy. To understand our views and practices regarding your personal data and how we will treat it please see www.dyoung.com/privacypolicy